DMAC logo

DiaMedica Therapeutics (DMAC) Operating Profit

Annual Operating Profit

-$21.27 M
-$7.27 M-51.90%

December 31, 2023


Summary


Performance

DMAC Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDMACprofitabilitymetrics:

Quarterly Operating Profit

-$6.88 M
-$1.25 M-22.08%

September 30, 2024


Summary


Performance

DMAC Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDMACprofitabilitymetrics:

TTM Operating Profit

-$24.11 M
-$1.73 M-7.71%

September 30, 2024


Summary


Performance

DMAC TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDMACprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

DMAC Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-51.9%-33.5%-24.3%
3 y3 years-70.2%-101.5%-64.4%
5 y5 years-283.4%-101.5%-64.4%

DMAC Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-55.9%at low-120.0%at low-81.6%at low
5 y5-year-98.1%at low-200.7%at low-146.6%at low
alltimeall time-9637.6%at low<-9999.0%at low<-9999.0%at low

DiaMedica Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$6.88 M(+22.1%)
-$24.11 M(+7.7%)
Jun 2024
-
-$5.64 M(-1.8%)
-$22.38 M(+4.2%)
Mar 2024
-
-$5.74 M(-1.8%)
-$21.49 M(+1.0%)
Dec 2023
-$21.27 M(+51.9%)
-$5.85 M(+13.4%)
-$21.27 M(+9.7%)
Sep 2023
-
-$5.16 M(+8.8%)
-$19.39 M(+11.7%)
Jun 2023
-
-$4.74 M(-14.1%)
-$17.36 M(+8.6%)
Mar 2023
-
-$5.52 M(+39.0%)
-$15.99 M(+14.2%)
Dec 2022
-$14.00 M(+2.6%)
-$3.97 M(+27.0%)
-$14.00 M(+5.5%)
Sep 2022
-
-$3.13 M(-7.0%)
-$13.27 M(-2.1%)
Jun 2022
-
-$3.36 M(-4.9%)
-$13.56 M(-0.0%)
Mar 2022
-
-$3.54 M(+8.9%)
-$13.56 M(-0.6%)
Dec 2021
-$13.65 M(+9.2%)
-$3.25 M(-5.0%)
-$13.65 M(-7.0%)
Sep 2021
-
-$3.42 M(+1.5%)
-$14.67 M(+0.8%)
Jun 2021
-
-$3.37 M(-7.0%)
-$14.55 M(+5.2%)
Mar 2021
-
-$3.62 M(-15.2%)
-$13.82 M(+10.6%)
Dec 2020
-$12.49 M(+16.4%)
-$4.27 M(+29.6%)
-$12.49 M(+15.7%)
Sep 2020
-
-$3.29 M(+24.6%)
-$10.80 M(+9.0%)
Jun 2020
-
-$2.64 M(+15.5%)
-$9.91 M(+1.3%)
Mar 2020
-
-$2.29 M(-11.2%)
-$9.78 M(-8.9%)
Dec 2019
-$10.74 M(+93.6%)
-$2.58 M(+7.5%)
-$10.74 M(+6.2%)
Sep 2019
-
-$2.40 M(-4.7%)
-$10.11 M(+12.3%)
Jun 2019
-
-$2.52 M(-22.5%)
-$9.00 M(+9.5%)
Mar 2019
-
-$3.25 M(+66.6%)
-$8.22 M(+48.2%)
Dec 2018
-$5.55 M(+29.8%)
-$1.95 M(+51.0%)
-$5.55 M(+16.5%)
Sep 2018
-
-$1.29 M(-25.5%)
-$4.76 M(+13.6%)
Jun 2018
-
-$1.73 M(+201.2%)
-$4.19 M(+17.8%)
Mar 2018
-
-$575.00 K(-50.6%)
-$3.56 M(-16.8%)
Dec 2017
-$4.28 M(+83.8%)
-$1.16 M(+61.5%)
-$4.28 M(+19.0%)
Sep 2017
-
-$720.30 K(-34.4%)
-$3.59 M(-6.2%)
Jun 2017
-
-$1.10 M(-15.0%)
-$3.83 M(+17.2%)
Mar 2017
-
-$1.29 M(+168.6%)
-$3.27 M(+40.5%)
Dec 2016
-$2.33 M(+60.8%)
-$481.20 K(-49.7%)
-$2.33 M(-4.3%)
Sep 2016
-
-$957.50 K(+78.5%)
-$2.43 M(+47.2%)
Jun 2016
-
-$536.40 K(+52.9%)
-$1.65 M(+14.7%)
Mar 2016
-
-$350.90 K(-40.1%)
-$1.44 M(-3.6%)
Dec 2015
-$1.45 M(-70.1%)
-$585.80 K(+228.4%)
-$1.49 M(-10.7%)
Sep 2015
-
-$178.40 K(-45.0%)
-$1.67 M(-29.6%)
Jun 2015
-
-$324.30 K(-20.0%)
-$2.38 M(-28.0%)
Mar 2015
-
-$405.30 K(-47.0%)
-$3.30 M(-32.7%)
Dec 2014
-$4.83 M
-$765.30 K(-13.2%)
-$4.91 M(-7.9%)
Sep 2014
-
-$881.40 K(-29.4%)
-$5.33 M(-7.5%)
Jun 2014
-
-$1.25 M(-37.9%)
-$5.76 M(-14.0%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$2.01 M(+69.7%)
-$6.70 M(-9.5%)
Dec 2013
-$7.41 M(-26.6%)
-$1.19 M(-9.5%)
-$7.40 M(-19.7%)
Sep 2013
-
-$1.31 M(-40.1%)
-$9.22 M(-12.2%)
Jun 2013
-
-$2.19 M(-19.3%)
-$10.50 M(-3.2%)
Mar 2013
-
-$2.71 M(-9.7%)
-$10.85 M(+8.8%)
Dec 2012
-$10.09 M(+51.8%)
-$3.01 M(+16.0%)
-$9.98 M(+12.1%)
Sep 2012
-
-$2.59 M(+2.1%)
-$8.90 M(+10.3%)
Jun 2012
-
-$2.54 M(+38.0%)
-$8.07 M(+14.3%)
Mar 2012
-
-$1.84 M(-4.7%)
-$7.06 M(+2.3%)
Dec 2011
-$6.65 M(+61.4%)
-$1.93 M(+9.4%)
-$6.90 M(+2.6%)
Sep 2011
-
-$1.76 M(+15.6%)
-$6.73 M(+12.4%)
Jun 2011
-
-$1.53 M(-9.3%)
-$5.98 M(+17.6%)
Mar 2011
-
-$1.68 M(-4.0%)
-$5.09 M(+32.1%)
Dec 2010
-$4.12 M(+68.7%)
-$1.75 M(+71.6%)
-$3.85 M(+43.1%)
Sep 2010
-
-$1.02 M(+61.5%)
-$2.69 M(+19.6%)
Jun 2010
-
-$632.50 K(+41.6%)
-$2.25 M(+7.3%)
Mar 2010
-
-$446.70 K(-24.6%)
-$2.10 M(-8.2%)
Dec 2009
-$2.44 M(+44.9%)
-$592.30 K(+2.0%)
-$2.29 M(+23.5%)
Sep 2009
-
-$580.50 K(+21.3%)
-$1.85 M(-6.1%)
Jun 2009
-
-$478.50 K(-24.6%)
-$1.97 M(-8.1%)
Mar 2009
-
-$634.40 K(+301.5%)
-$2.15 M(+10.2%)
Dec 2008
-$1.69 M(-27.0%)
-$158.00 K(-77.5%)
-$1.95 M(-19.4%)
Sep 2008
-
-$701.10 K(+7.4%)
-$2.42 M(+14.1%)
Jun 2008
-
-$652.80 K(+50.1%)
-$2.12 M(-14.5%)
Mar 2008
-
-$435.00 K(-30.7%)
-$2.48 M(+11.9%)
Dec 2007
-$2.31 M(+193.4%)
-$628.00 K(+56.3%)
-$2.21 M(+22.6%)
Sep 2007
-
-$401.80 K(-60.3%)
-$1.81 M(+9.8%)
Jun 2007
-
-$1.01 M(+494.2%)
-$1.65 M(+161.5%)
Mar 2007
-
-$170.50 K(-22.7%)
-$629.20 K(+38.0%)
Dec 2006
-$787.20 K(+260.4%)
-$220.50 K(-8.6%)
-$455.80 K(+93.7%)
Sep 2006
-
-$241.20 K(-8140.0%)
-$235.30 K(-4088.1%)
Jun 2006
-
$3000.00(+3.4%)
$5900.00(+103.4%)
Mar 2006
-
$2900.00(-53.2%)
$2900.00(-101.1%)
Dec 2005
-$218.40 K(-65.7%)
-
-
Mar 2005
-
$6200.00(-103.1%)
-$270.00 K(-6.3%)
Dec 2004
-$636.70 K
-
-
Dec 2004
-
-$200.90 K(+1213.1%)
-$288.30 K(+74.3%)
Sep 2004
-
-$15.30 K(-74.5%)
-$165.40 K(-2.2%)
Jun 2004
-
-$60.00 K(+395.9%)
-$169.20 K(+42.3%)
Mar 2004
-
-$12.10 K(-84.5%)
-$118.90 K(+11.3%)
Dec 2003
-
-$78.00 K(+308.4%)
-$106.80 K(+270.8%)
Sep 2003
-
-$19.10 K(+96.9%)
-$28.80 K(+196.9%)
Jun 2003
-
-$9700.00
-$9700.00

FAQ

  • What is DiaMedica Therapeutics annual operating income?
  • What is the all time high annual operating profit for DiaMedica Therapeutics?
  • What is DiaMedica Therapeutics annual operating profit year-on-year change?
  • What is DiaMedica Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for DiaMedica Therapeutics?
  • What is DiaMedica Therapeutics quarterly operating profit year-on-year change?
  • What is DiaMedica Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for DiaMedica Therapeutics?
  • What is DiaMedica Therapeutics TTM operating profit year-on-year change?

What is DiaMedica Therapeutics annual operating income?

The current annual operating profit of DMAC is -$21.27 M

What is the all time high annual operating profit for DiaMedica Therapeutics?

DiaMedica Therapeutics all-time high annual operating income is -$218.40 K

What is DiaMedica Therapeutics annual operating profit year-on-year change?

Over the past year, DMAC annual operating income has changed by -$7.27 M (-51.90%)

What is DiaMedica Therapeutics quarterly operating income?

The current quarterly operating profit of DMAC is -$6.88 M

What is the all time high quarterly operating profit for DiaMedica Therapeutics?

DiaMedica Therapeutics all-time high quarterly operating income is $6200.00

What is DiaMedica Therapeutics quarterly operating profit year-on-year change?

Over the past year, DMAC quarterly operating income has changed by -$1.73 M (-33.47%)

What is DiaMedica Therapeutics TTM operating income?

The current TTM operating profit of DMAC is -$24.11 M

What is the all time high TTM operating profit for DiaMedica Therapeutics?

DiaMedica Therapeutics all-time high TTM operating income is $5900.00

What is DiaMedica Therapeutics TTM operating profit year-on-year change?

Over the past year, DMAC TTM operating income has changed by -$4.72 M (-24.33%)